The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, an investigational therapy being developed by Sanofi for people with…
Myeloma
During my mom’s last support group meeting, the facilitator asked all the participants to introduce themselves and identify their cancer by name. One after the…
Johnson & Johnson‘s Darzalex (daratumumab) is now the first approved treatment for high-risk smoldering multiple myeloma (SMM) in the European Union (EU). SMM…
“You are very strong.” People say this as if it’s a compliment. Sometimes when I hear it, I smile back at them and mutter, “Thank…
Two combination therapies using Blenrep (belantamab mafodotin) — designed to treat adults with relapsed or refractory multiple myeloma — have been approved in the…
When I wake up in the morning, I do the same things in the same order: Examine the pillbox. Send a text to my mum…
Ichnos Glenmark Innovation (IGI) is partnering with Abbvie to advance the development of ISB 2001, a multiple myeloma treatment candidate that’s now in…
I have quite a lot of friends who are caregivers like me. Every day and night, they provide care, attention, and company to their patients,…
The U.S. Food and Drug Administration (FDA) has approved label updates for two Bristol Myers Squibb (BMS) CAR T-cell therapies, both for the treatment…
There is an unspoken rule that seems to apply to all cancer caregivers. It goes something like this: You should always be serious, present, and…
Recent Posts
- AI offers answers to patients about multiple myeloma
- Cadonilimab combo boosts survival in advanced pancreatic cancer patients
- A secondary diagnosis shows me how far I’ve come as a caregiver
- New targeted therapy Ojemda approved in EU for pediatric glioma
- Mo-Rez shows strong early responses in ovarian, endometrial cancers
